Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania

Sexually Transmitted Diseases

Volumn 40, Issue 9, 2013, Pages 737-743

  Dartell, Myassa ^a   Rasch, Vibeke ^b   Munk, Christian ^a   Kahesa, Crispin ^c   Mwaiselage, Julius ^c   Iftner, Thomas ^d   Kjaer, Susanne Krüger ^a,e  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Ocean Road Cancer Institute   (Tanzania)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CONDYLOMA ACUMINATUM; CROSS-SECTIONAL STUDY; EDUCATION; FEMALE; GENOTYPE; HIGH RISK PATIENT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIFESTYLE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; REPRODUCTIVE HISTORY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; TANZANIA; UNDERWEIGHT; VIRUS DETECTION; WART VIRUS;

ADULT; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARTURITION; PREVALENCE; RISK FACTORS; SEXUAL PARTNERS; TANZANIA;

EID: 84883303795     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000005     Document Type: Article

References (31)

1. Dartell M, Rasch V, Kahesa C, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: The PROTECT study. Sex Transm Dis 2012; 39:201-208.
2. Nielsen A, Kjaer SK, Munk C, et al. Type-specific HPV infection and multiple HPV types: Prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 2008; 35:276-282.
3. Kahn JA, Rosenthal SL, Succop PA, et al. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 2002; 109:E5.
4. Vaccarella S, Herrero R, Dai M, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: Pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15:2148-2153.
5. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191:1796-1807.
6. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(suppl 1):S1-S15.
7. Franceschi S., Herrero R, Clifford GM, et al. Variations in the agespecific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119:2677-2684.
8. González P, Hildesheim A, Rodríguez AC, et al. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev 2010; 19:3044-3054. Epub 2010 Oct 15.
9. Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health 2008; 43(4 suppl):S5-S25, S25.e1-e41. Review.
10. Kjaer SK, Breugelmans G, Munk C, et al. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008; 123:1864-1870.
11. Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003; 80-8. Review.
12. Blossom DB, Beigi RH, Farrell JJ, et al. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol 2007; 79:758-765.
13. Wang C, Wright TC, Denny L, et al. Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J Infect Dis 2011; 203:479-486. Epub 2011 Jan 7.
14. Clifford GM, Gonçalves MA, Franceschi S. HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: A meta-analysis. AIDS 2006; 20:2337-2344.
15. Silva RJ, Casseb J, Andreoli MA, et al. Persistence and clearance of HPV from the penis of men infected and non-infected with HIV. J Med Virol 2011; 83:127-131.
16. Kang M, Cu-Uvin S. Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Med 2012; 13:372-378. 10.1111/j.1468-1293.2011.00979.x.
17. Auvert B, Lissouba P, Cutler E, et al. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 2010; 53:111-116.
18. Smith JS, Moses S, Hudgens MG, et al. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 2010; 201:1677-1685.
19. Smith-McCune KK, Shiboski S, Chirenje MZ, et al. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One 2010; 5:e10094.
20. Hernández-Girón C, Smith JS, Lorincz A, et al. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis 2005; 32:613-618.
21. Hildesheim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Wachintong, D.C. Sex Transm Dis 1993; 20:279-285.
22. Crum-Cianflone NF, Roediger M, Eberly LE, et al. Infectious Disease Clinical Research Program HIV Working Group. Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol 2011; 18:940-946. Epub 2011 Apr 27.
23. Gerriets VA, Rathmell JC. Metabolic pathways in T cell fate and function. Trends Immunol 2012; 33:168-173. Epub 2012 Feb 17. Review.
24. del Amo J, González C, Belda J, et al. Prevalence and risk factors of high-risk human papillomavirus in female sex workers in Spain: Differences by geographical origin. J Womens Health (Larchmt) 2009; 18:2057-2064.
25. Tobian AA, Kong X, Wawer MJ, et al. Circumcision of HIVinfected men and transmission of human papillomavirus to female partners: Analyses of data from a randomised trial in Rakai, Uganda. Lancet Infect Dis 2011; 11:604-612. Epub 2011 Apr 12.
26. Templeton DJ. Male circumcision to reduce sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:344-349.
27. Gray RH, Serwadda D, Kong X, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: A randomized trial in Rakai, Uganda. J Infect Dis 2010; 201:1455-1462.
28. Serwadda D, Wawer MJ, Makumbi F, et al. Circumcision of HIVinfected men: Effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda. J Infect Dis 2010; 201:1463-1469.
29. WHO and UNAIDS. New data on male circumcision and HIV prevention: Policy and programme implications. Geneva, 2007. Available at: Http://data.unaids.org/ pub/Report/2007/mc-recommendations-en.pdf.
30. Syrjanen K, Kulmala SM, Shabalova I, et al. Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly women. Eur J Gynaecol Oncol 2008; 29:114-122.
31. Clarke MA, Gage JC, Ajenifuja KO, et al. A population-based crosssectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infect Agent Cancer 2011; 6:12.